Further Analysis Clause Samples
The 'Further Analysis' clause requires one or both parties to conduct additional investigation or assessment on specific matters relevant to the agreement. In practice, this may involve gathering more data, performing technical evaluations, or seeking expert opinions to clarify uncertainties or support decision-making. This clause ensures that any unresolved issues or ambiguities are thoroughly examined before finalizing actions or commitments, thereby reducing the risk of misunderstandings or incomplete information.
Further Analysis. Debt to Asset Ratio is greater than or equal to .50 Does Not Meet Target: Upon further review following a preliminary Pending rating, the Commission concludes that there is financial risk such that heightened monitoring and/or intervention may be warranted. A Does Not Meet rating means that even based on more current financial information, the school is not currently meeting the target or concerns previously identified, although not currently manifested, have been of a depth or duration that warrants continued attention.
Further Analysis. 🞏 Debt to Asset Ratio is greater than or equal to .50
Further Analysis. 🞏 Enrollment Variance is below 95% in the most recent year Does Not Meet Target: 🞏 Upon further review following a preliminary Pending rating, the Commission concludes that there is financial risk such that heightened monitoring and/or intervention may be warranted. A Does Not Meet rating means that even based on more current financial information, the school is not currently meeting the target or concerns previously identified, although not currently manifested, have been of a depth or duration that warrants continued attention.
Further Analysis. 🞏 Fund balance percentage is less than 25% Does Not Meet Target: 🞏 Upon further review following a preliminary Pending rating, the Commission concludes that there is financial risk such that heightened monitoring and/or intervention may be warranted. A Does Not Meet rating means that even based on more current financial information, the school is not currently meeting the target or concerns previously identified, although not currently manifested, have been of a depth or duration that warrants continued attention.
Further Analysis. The Declaration aims to respond to the concerns expressed about the possible implications of the TRIPs Agreement for access to drugs. It does so in a number of ways. 230 WTO Agreements and public health.op.cit. 231 ▇▇▇▇▇-▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, Human Rights and the Law of the World Trade Organization *Journal of World Trade 37(2): 241–281, 2003. _ 2003 Kluwer Law International. 232 See WTO document WT/MIN (01)/DEC/W/2 of 14 November 2001, para. 4. First, it emphasizes that the TRIPs Agreement does not and should not prevent Members from taking measures to protect public health and reaffirms the right of Members to use, to the full, the provisions of the TRIPs Agreement which provide flexibility for this purpose. These important Declarations signal an acceptance by all WTO Members that they will not seek to prevent other Members from using these provisions.233 Second, the Declaration makes it clear that the TRIPs Agreement should be interpreted and implemented in a manner supportive of WTO Members' right to protect public health and, in particular, to promote access to medicines for all. Further, it highlights the importance of the objectives and principles of the TRIPs Agreement for the interpretation of its provisions. Although the Declaration does not refer specifically to Articles 7 and 8 of the TRIPs Agreement, entitled, respectively, "Objectives" and "Principles", it should be noted that developing country Members attach particular importance to these provisions. These statements thus provide important guidance to both individual Members and, in the event of disputes, WTO dispute settlement bodies. Third, the Declaration contains a number of important clarifications of some of the flexibilities contained in the TRIPs Agreement, while maintaining Members' commitments in the TRIPs Agreement. With regard to the least-developed country Members of the WTO, the Declaration accords them an extension of their transition period until the beginning of 2016 for the protection and enforcement of patents and rights in undisclosed information with respect to pharmaceutical products. Until then, these countries are exempt from these TRIPs obligations. And also, the TRIPs Council was mandated to find an expeditious solution to the problem of WTO Members with limited manufacturing capacities in making effective use of compulsory licencing and to report to the General Council before the end of 2002. It should also be noted that, while emphasizing the scope in the TRIPs Agre...
Further Analysis. Energy temperature curve Energy conusmption [kWh/m²week]
Further Analysis. In this instance, if ▇▇▇▇▇ has some difficulties in concluding on the effectiveness of the treatment on the specific patient. He might want to consult his colleagues, the radiologist and another clinician, ▇▇▇▇▇ who are located elsewhere, to exchange ideas and collaboratively reach a decision. At present, there is no easy way to share data in real time for joint discussion.